4
Changes in Ownership
Acrivon Therapeutics, Inc. Filed Acc 0001209191-22-057398
Chief Financial Officer acquired 20,030 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Holm-Jorgensen Rasmus · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-11-14 | Grant or award : show line 1 in the form | +20,030 | 20,030 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-11-14 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +60,090 | 60,090 | D |
Loading xslF345X03/doc4.xml…